|
ZNF624 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.587400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.190800E-01 |
| Normal-vs-Stage2 |
6.460000E-01 |
| Normal-vs-Stage3 |
2.071200E-01 |
| Normal-vs-Stage4 |
1.596010E-02 |
| Stage1-vs-Stage2 |
7.445200E-01 |
| Stage1-vs-Stage3 |
1.983440E-01 |
| Stage1-vs-Stage4 |
2.264300E-03 |
| Stage2-vs-Stage3 |
5.734800E-01 |
| Stage2-vs-Stage4 |
6.220200E-02 |
| Stage3-vs-Stage4 |
1.768370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.323200E-01 |
| Normal-vs-AfricanAmerican |
6.597200E-01 |
| Normal-vs-Asian |
2.733600E-01 |
| Caucasian-vs-AfricanAmerican |
6.527000E-01 |
| Caucasian-vs-Asian |
4.816800E-01 |
| AfricanAmerican-vs-Asian |
5.142800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.255200E-01 |
| Normal-vs-Female |
1.175040E-01 |
| Male-vs-Female |
5.915400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.485200E-01 |
| Normal-vs-Extreme_Weight |
3.261400E-01 |
| Normal-vs-Obese |
8.965000E-01 |
| Normal-vs-Extreme_Obese |
3.852400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.066600E-01 |
| Normal_Weight-vs-Obese |
9.359000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.795400E-01 |
| Extreme_Weight-vs-Obese |
3.909800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.401400E-01 |
| Obese-vs-Extreme_Obese |
5.080000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.825600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.688400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.713000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.150100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.246400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.061200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.051000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.445800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.355800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.947600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.451200E-01 |
| Normal-VS-Type2 PRCC |
2.501600E-02 |
| Normal-VS-KIRP CIMP |
1.070020E-02 |
| Normal-VS-Unclassified PRCC |
3.629800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.389000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.221140E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.662000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.282000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.060460E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.840700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.203600E-02 |
| Normal-vs-N1 |
5.349800E-01 |
| Normal-vs-N2 |
2.212100E-02 |
| N0-vs-N1 |
2.328800E-01 |
| N0-vs-N2 |
1.718780E-01 |
| N1-vs-N2 |
9.350400E-02 |
|
|
